Pen and Autoinjectors: Testing for the Future

The injectable drug-delivery device market is growing at a staggering rate, with an anticipated global market value of $37.5 billion by 2025 compared to $16.7 billion in 2016. The driving factors of this growth are the increasing geriatric population and the rising incidence rates of chronic and autoimmune diseases such as diabetes and multiple sclerosis. Allergies causing anaphylactic reactions are also increasing dramatically, particularly in industrially developed countries.